oxazolidin-2-one has been researched along with Infection, Mycobacterium avium-intracellulare in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Jhun, BW; Kim, LH; Kim, SY; Lee, JM; Lee, W; Shin, SJ | 1 |
Bertó, J; Del Pozo, JL; Leiva, J; Yuste, JR | 1 |
Carson, J; Cerda, J; Chae, JH; Hirano, M; Maggiore, P | 1 |
Falagas, ME; Ntziora, F | 1 |
Binstock, P; Keating, M; Kontoyiannis, DP; Nannini, EC; Samonis, G | 1 |
1 review(s) available for oxazolidin-2-one and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review.
Topics: Acetamides; Adolescent; Adult; Anemia; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Optic Nerve Diseases; Oxazolidinones; Peripheral Nervous System Diseases; Treatment Outcome; Tuberculosis | 2007 |
4 other study(ies) available for oxazolidin-2-one and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Lung Diseases; Macrolides; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones | 2023 |
Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.
Topics: Aged; Anti-Bacterial Agents; Drug Tolerance; Humans; Linezolid; Lung; Male; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nontuberculous Mycobacteria; Oxazolidinones; Tetrazoles; Time Factors | 2017 |
Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism.
Topics: Acetamides; Acidosis, Lactic; Adult; Anti-Infective Agents; DNA, Mitochondrial; Female; Genetic Predisposition to Disease; Humans; Linezolid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Polymorphism, Genetic | 2007 |
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linezolid; Male; Mefloquine; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Quinolines | 2002 |